Mitsuhiro Sato
Chief Operating Officer at Fujifilm Kyowa Kirin Biologics Co., Ltd.
Network origin in Mitsuhiro Sato first degree
Entity | Entity type | Industry | |
---|---|---|---|
Centus Biotherapeutics Ltd.
Centus Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Centus Biotherapeutics Ltd. is a British company that develops and manufactures biologic products. The joint venture company is based in Cambridge, UK. The company was founded in 2015.
3
| Joint Venture | Pharmaceuticals: Major | 3 |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. is a Japanese company that is not well described by the given metadata. The joint venture company is based in Tokyo, Japan. However, based on the company name, it is likely that they are involved in the biotechnology or pharmaceutical industry. The company was founded in 2012. The CEO is Yoshifumi Torii.
2
| Joint Venture | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mitsuhiro Sato via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Archigen Biotech Ltd.
Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
KYOWA KIRIN CO. LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CooperVision, Inc.
CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | Medical Specialties | Corporate Officer/Principal | |
NEXIMMUNE, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Harvard College | College/University | Undergraduate Degree | |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Corporate Officer/Principal | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Chief Operating Officer |
Statistics
International
United States | 7 |
United Kingdom | 3 |
Japan | 2 |
Sectoral
Health Technology | 8 |
Consumer Services | 3 |
Operational
Director/Board Member | 8 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 1 |
President | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Most connected contacts
Insiders | |
---|---|
John Trainer | 8 |
Yoshifumi Torii | 3 |
Alex Wilkes | 3 |
Karl David Bradshaw | 2 |
- Stock Market
- Insiders
- Mitsuhiro Sato
- Company connections